P
Pairwise
Developing new and delicious types of leafy greens, berries, and cherries
About Pairwise
Pairwise is a groundbreaking startup operating in the food and agriculture sector, with a primary focus on health. The company is on a mission to revolutionize our food system by leveraging advanced gene-editing techniques, such as CRISPR, to create innovative plant-based products. These products range from pitless cherries to crops with higher yields and greater adaptability to climate change.
Read full description
The company's target market includes consumers seeking healthier and more sustainable food options, as well as businesses in the food and agriculture industry looking for innovative solutions to improve their supply chains. Pairwise's business model is centered around its proprietary Fulcrum™ platform, which accelerates innovation in plants and plant-based production systems.
The company generates revenue by creating and selling these gene-edited products. They have a unique advantage in the market due to their exclusive intellectual property and in-house designed tools, which allow them to deliver these products faster and more effectively than their competitors.
To date, Pairwise has successfully grown gene-edited varieties in the field across four different crops and is set to bring the first CRISPR-edited food products to the U.S. market this year. This indicates a promising future for the company as it continues to pioneer in the realm of gene-edited food products.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Durham, United States
- Employees
- 114
- Open positions
- 1
- Dealroom signal
- 74.0/100
- Industry
- Food
- Sub-industry
- AgriTech, Innovative Food
- Sector
- Food, Biotechnology, DNA, Genetics and genomics, Crispr, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning Pairwise.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Sep 2024 | $40M | $450M | Deerfield · Leaps by Bayer · Corteva · Aliment Capital | ↗ |
| SERIES BOther financing | Feb 2021 | $90M | $360M | Leaps by Bayer · Temasek · Deerfield · Pontifax AgTech | — |
Growth signals
Latest recorded traffic for Pairwise is 7.4K monthly website visits, down 38.3% over the last three months. Pairwise's team grew 2.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Deerfield
Monsanto- MVMonsanto Growth Ventures
Pontifax AgTech
Leaps by Bayer
Temasek
Series B and later2 investors entered at this stage
Corteva
Aliment Capital
Other known investors1 additional known investor
Harvard University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pairwise on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pairwise’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.